Personally, I can't see Big Pharma allowing MSB to be publicly listed when the back pain trial results start coming in......
They will have to make a move before then or the cheapness will disappear.
Other catalysts remain but they are not as sure a thing so they have been happy to wait while the general bear market does its thing for them.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-103
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.712B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.153M | 3.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2371 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 2383 | 2 |
View Market Depth
| Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |